OUR BUY SIGNAL IN THE FACE OF MULTIPLE DOWNGRADES BY THE WALL STREET ON $BSX (BOSTON SCIENTIFIC) HAS PROVEN TO BE THE CORRECT CALL

Twitter
LinkedIn
Facebook
On March 15,2010 when Boston Scientific’s defibrillators were taken off the market, the Wall Street uniformly issued downgrades. Goldman Sachs downgraded to Conviction Sell.: JP Morgan said sell, Barron’s urged investors to sell and the sell chorus chimed throughout the Wall Street. More specifically, several Gurus pronounced that the products would not return to the market for several months.

In the face of the Wall Street’s unanimous selling calls, we issues a buy signal — the fact that we were familiar with the manufacturing process added conviction to our call. More specifically, our analysis showed that the infractions were minor paperwork infractions and our best estimate was that the products may return to the market in as few as 30 days.

On April 15, 2010 , exactly one month later,FDA allowed the products to return to the market.

Course of Action on BSX shares
We are long from $6.32. In the premarket, the stock traded as high as $7.85 — a gain of 24.2 %
in one month or 290.5% annualized. Considering out first scale out target was $8, those following the ZYX Change Method should have lightened the holding as it failed to reach the $8 mark.
For those who still hold it, we recommend holding the core position and exiting the rest based on technicals.
It is given that $BSX will report terrible earnings for the last quarter and the guidance for the present quarter will be lowered. We will take advantage of any weakness on the earnings to accumulate the shares based on technicals, preferaby in the range of $5 to $5.70.

Subscribe to 'Generate Wealth'

Free Forever

More To Explore

30 Day Free Trial

Cancel within 30 days and you owe nothing

When you take a FREE 30 day trial, you get access to powerful techniques used by billionaires and hedge funds to grow richer. You can continue to use these powerful techniques to grow richer even if you cancel your subscription. You come out ahead by subscribing no matter how you look at it.

A fortune is to be made from AI stocks.
Get the list of 18 AI stocks to grab your share of the profits — no cost to you.

A fortune is to be made from AI stocks.

Get the list of 18 AI stocks to grab your share of the profits.

AI is a $1 Trillion Market

Making A Fortune
In Artificial Intelligence

Golden Age of Artificial Intelligence